A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)
- Citation:
- Clin. Pharmacol. Ther. vol 105 (3) 738-745
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- Yes
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- None
- Children:
- None
- Pharmas:
- Celgene, BMS
- Grants:
- U10CA180821, U10CA180882, U10CA180833, U24CA19617, U10CA180836, U10CA180838, U10CA180867
- Corr. Author:
- Authors:
- Sara R. Rashkin Katherina C. Chua Carol Ho Flora Mulkey Chen Jiang Tasei Mushiroda Michiaki Kubo Paula N. Friedman Hope S. Rugo Howard L. McLeod Mark J. Ratain Francisco Castillos Michael Naughton Beth Overmoyer Deborah Toppmeyer John S. Witte Kouros Owzar Deanna L. Kroetz
- Networks:
- CA824, DE012, HEARTLAND, LAPS-IL036, LAPS-IL057, LAPS-MA036, SCOR
- Study
- CALGB-40502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- prediction model, pharmacogenomics, breast cancer, microtubule targeting agents